Centerpoint Advisors’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-250
Closed -$24K 385
2024
Q4
$24K Hold
250
0.01% 233
2024
Q3
$24K Hold
250
0.01% 238
2024
Q2
$21K Hold
250
0.01% 252
2024
Q1
$21K Hold
250
0.01% 234
2023
Q4
$21K Hold
250
0.01% 221
2023
Q3
$18K Buy
+250
New +$19K 0.01% 237
2022
Q4
Sell
-100
Closed -$6K 478
2022
Q3
$6K Hold
100
﹤0.01% 246
2022
Q2
$5K Hold
100
﹤0.01% 263
2022
Q1
$6K Hold
100
﹤0.01% 257
2021
Q4
$5K Hold
100
﹤0.01% 268
2021
Q3
$5K Hold
100
﹤0.01% 227
2021
Q2
$6K Hold
100
﹤0.01% 224
2021
Q1
$7K Hold
100
﹤0.01% 188
2020
Q4
$5K Hold
100
﹤0.01% 196
2020
Q3
$4K Hold
100
﹤0.01% 189
2020
Q2
$4K Hold
100
﹤0.01% 214
2020
Q1
$4K Hold
100
﹤0.01% 189
2019
Q4
$4K Hold
100
﹤0.01% 215
2019
Q3
$3K Hold
100
﹤0.01% 218
2019
Q2
$4K Hold
100
﹤0.01% 195
2019
Q1
$3K Hold
100
﹤0.01% 203
2018
Q4
$3K Buy
+100
New +$2.75K ﹤0.01% 193

Other funds holding ACA

Centerpoint Advisors's ACA Position: Q1 2025 in Review

Centerpoint Advisors sold out of Arcosa (ACA) in Q1 2025, closing a stake of 250 shares — an estimated $24K sold.

Centerpoint Advisors first reported a position in ACA in Q4 2018 and held it in 22 quarters. The position peaked at $24K in Q4 2024. 314 funds tracked by Wall St. Rank hold ACA as of Q1 2025.

  • Centerpoint Advisors reported no remaining Arcosa position as of Q1 2025 after selling out during the quarter.
  • Centerpoint Advisors sold 250 Arcosa shares in Q1 2025, an estimated $24K.
  • Centerpoint Advisors first reported a position in Arcosa in Q4 2018 and held it in 22 quarters.
  • Centerpoint Advisors's Arcosa position peaked at $24K in Q4 2024.
  • 314 funds tracked by Wall St. Rank held Arcosa as of Q1 2025.

Based on Centerpoint Advisors's 13F filing for Q1 2025, filed 13 May 2025.